Complete CCDS-O ACDIS Materials

To establish and query for a patient’s baseline renal function in the outpatient setting, eGFR is the most direct and standardized measure because it estimates kidney filtration capacity using serum creatinine (and patient factors such as age/sex, and sometimes race depending on the equation used). Outpatient CDI concepts emphasize that chronic kidney disease staging is based primarily on eGFR categories (G1–G5) and persistence over time, making eGFR trends particularly useful for determining whether the patient has CKD, whether it is worsening, and what stage should be documented. Serum creatinine alone can suggest decline but does not translate cleanly to CKD stage without calculating eGFR and considering patient characteristics. BUN is influenced by hydration status, protein intake, bleeding, and catabolic states, so it is less reliable for baseline kidney function assessment. ACR is important for detecting albuminuria and refining CKD classification/risk stratification, but it complements eGFR rather than replacing it as the primary indicator of baseline filtration function.

A key ambulatory CDI distinction between the two major risk models is timing. The HHS-HCC model (used for ACA Marketplace risk adjustment) is commonly described as a concurrent model: it uses the enrollee’s demographics and diagnoses from the same benefit year to reflect morbidity and support that year’s risk transfer/payment balancing. In contrast, the CMS-HCC model (commonly applied in Medicare Advantage) is prospective: conditions documented and coded in the prior data collection year are used to predict expected cost for the following payment year. From an outpatient CDI perspective, this timing difference affects operational priorities. For CMS-HCC, accurate annual capture and recapture of active chronic conditions is essential because last year’s documented conditions drive next year’s risk score and revenue. For HHS-HCC, complete documentation and coding during the current year impacts the current year’s risk measurement. Options referencing CPT codes are not correct for the core HCC risk score calculation, which is driven by demographics and ICD diagnosis reporting mapped to HCC categories.

Outpatient CDI programs should share provider-facing metrics that are clinically meaningful, aligned with ambulatory documentation goals, and unlikely to be perceived as payment-driven prompting.RAF scoresare an appropriate metric because they reflect how well the documented and coded condition burden represents the patient panel’s complexity in risk adjustment models. Discussing RAF supports education around accurate diagnosis capture, specificity, and annual recapture of active chronic conditions that are monitored, evaluated, assessed/addressed, or treated. In contrast,APC payment ratesare facility OPPS payment constructs and typically are not actionable for individual ambulatory provider documentation improvement.HCC per member per month paymentsis explicitly financial and can create compliance risk by tying documentation discussions directly to payment, which outpatient CDI guidance warns against in provider messaging.MCC ratesare primarily an inpatient DRG severity concept and are not the most relevant outpatient performance measure. Therefore, RAF scores best balance provider relevance, program goals, and compliant education focus.

MIPS (Merit-based Incentive Payment System) is the default Medicare Quality Payment Program pathway for most eligible clinicians who are not sufficiently participating in an Advanced APM. In practice, if a clinician is MIPS-eligible and does not meet reporting requirements (or performs poorly), Medicare applies a negative payment adjustment—so “non-participation” effectively carries financial risk. APMs (Alternative Payment Models), especially Advanced APMs, are not automatically required for all clinicians; they are model-based arrangements (often tied to specific payers, contracts, patient populations, and risk/quality terms) that clinicians typically enter through organizational participation decisions. A key operational difference emphasized in outpatient CDI education is that MIPS performance hinges on accurate, complete documentation supporting quality measures and resource use across a broad clinician population, whereas APM participation depends on being in a qualifying model and meeting its participation/threshold rules. Therefore, MIPS functions as the required/default track with potential penalties, while APM participation is elective and model-dependent.